Metabolic effects of unilateral lesion of the substantia nigra
- PMID: 7264720
- PMCID: PMC6564122
- DOI: 10.1523/JNEUROSCI.01-03-00285.1981
Metabolic effects of unilateral lesion of the substantia nigra
Abstract
Regional brain glucose utilization following unilateral lesion of the substantia nigra in rat was studied by [14C]-2-deoxyglucose autoradiography. Substantia nigra lesions were performed by perinigral injections of 6-hydroxydopamine (6-OHDA) . HBr, 6 microgram, in rats pretreated 30 min earlier with desmethylimipramine (DMI), 25 mg/kg, subcutaneously. The lesion produced extensive destruction of the ipsilateral substantia nigra pars compacta and a greater than 99% reduction in dopamine concentration in the ipsilateral striatum. Pretreatment with DMI prevented any reduction in the concentration of norepinephrine in ipsilateral forebrain structures. Glucose utilization was increased in the ipsilateral globus pallidus at 11, 21, 53, and 104 days after substantia nigra lesion with the largest increase (about 140% of control) occurring at 21 days post-lesion. In addition, glucose utilization in ipsilateral lateral habenular nucleus was increased at each of the above time points. No changes in glucose utilization were noted in frontal cortex, striatum, subthalamic nucleus, entopeduncularis, or ventral tier nuclei of the thalamus. These results suggest that lesion of the substantia nigra with depletion of striatal dopamine content results in disinhibition of some striatal, and perhaps olfactory cortical, efferents producing increased metabolism and glucose utilization in terminal fields within the globus pallidus and lateral habenular nucleus.
Similar articles
-
Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions.J Neurosci. 1987 Sep;7(9):2927-35. doi: 10.1523/JNEUROSCI.07-09-02927.1987. J Neurosci. 1987. PMID: 3114439 Free PMC article.
-
The effects of L-DOPA on regional cerebral glucose utilization in rats with unilateral lesions of the substantia nigra.Brain Res. 1986 Aug 6;379(2):264-74. doi: 10.1016/0006-8993(86)90780-8. Brain Res. 1986. PMID: 3527339
-
Bilateral cerebral metabolic effects of pharmacological manipulation of the substantia nigra in the rat: unilateral intranigral application of the putative excitatory neurotransmitter substance P.Neuroscience. 1992 Oct;50(4):795-809. doi: 10.1016/0306-4522(92)90205-g. Neuroscience. 1992. PMID: 1280349
-
Bilateral cerebral metabolic effects of pharmacological manipulation of the substantia nigra in the rat: unilateral intranigral application of the inhibitory GABAA receptor agonist muscimol.Neuroscience. 1992 Oct;50(4):781-94. doi: 10.1016/0306-4522(92)90204-f. Neuroscience. 1992. PMID: 1333060
-
Unilateral peri-substantia nigra catecholaminergic lesion and amygdala kindling.Brain Res. 1986 Apr 9;370(2):388-92. doi: 10.1016/0006-8993(86)90500-7. Brain Res. 1986. PMID: 3085869
Cited by
-
Redistribution of cardiac output after hypothalamic lesions and hemorrhage.Exp Brain Res. 1987;69(1):107-12. doi: 10.1007/BF00247033. Exp Brain Res. 1987. PMID: 3436382
-
Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease.Neuroimage. 2012 May 15;61(1):228-39. doi: 10.1016/j.neuroimage.2012.02.066. Epub 2012 Mar 3. Neuroimage. 2012. PMID: 22406356 Free PMC article.
-
Modulation effect of substantia nigra iron deposition and functional connectivity on putamen glucose metabolism in Parkinson's disease.Hum Brain Mapp. 2022 Aug 15;43(12):3735-3744. doi: 10.1002/hbm.25880. Epub 2022 Apr 26. Hum Brain Mapp. 2022. PMID: 35471638 Free PMC article.
-
Characterization of the resting-state brain network topology in the 6-hydroxydopamine rat model of Parkinson's disease.PLoS One. 2017 Mar 1;12(3):e0172394. doi: 10.1371/journal.pone.0172394. eCollection 2017. PLoS One. 2017. PMID: 28249008 Free PMC article.
-
Catecholamine depletion in first-degree relatives of individuals with mood disorders: An [(18)F]fluorodeoxyglucose positron emission tomography study.Neuroimage Clin. 2013 Mar 5;2:341-55. doi: 10.1016/j.nicl.2013.02.004. eCollection 2013. Neuroimage Clin. 2013. PMID: 24179788 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous